Industry-leading technology

At Cellino, we unite deep tech and biomedicine within an autonomous biomanufacturing platform capable of scaling production of personalized regenerative cells, tissues, and organs—all from a patient’s own cells.

Our Technology

Our proprietary technology stack unlocks the power of personalized regenerative medicine.

AI-driven optical bioprocesses make patient-specific biomanufacturing a reality.

1.0

Deep Learning

Our AI algorithms consistently deliver reproducible, scalable biomanufacturing, far exceeding traditional manual methods.

1.0

Cellinoverse

A digital environment simulating life-like biomanufacturing behavior in silico

2.0

Laser cell management

Laser-generated bubbles precisely remove unwanted cells to control cell density with unprecedented precision.

2.0

Optical Bioprocess

A closed-loop, image-guided optical bioprocess delivers consistent, reproducible results over time by minimizing human variability.

3.0

Tech Stack

3.0

Tech Stack

The Nebula platform compresses traditional infrastructure into modular, cassette-based systems, enabling scalable deployment. These systems can power large-scale distributed foundries or be localized in hospitals, dramatically expanding patient access to advanced treatments.

Nebula powers the scalable production of biologically younger, living medicines—transformative, one-time treatments for chronic degenerative conditions. By leveraging self-sourced therapies, it eliminates the need for immunosuppression, dramatically expanding patient access and treatment potential.

A BioFoundry Future

Send order to BioFoundry
Fabricate at BioFoundry
Transplant “fresh” therapy

Our impact and potential

890Mpatients affected by Obesity

400Mpatients affected by T2 Diabetes

21.5Mpatients affected by Alzheimer's

850Mpatients affected by Chronic Kidney Disease

196Mpatients affected by Macular Degeneration

1Bpatients affected by Metabolic Syndrome